Projects funded by the NCN
Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic strategy of depression.
2017/26/M/NZ7/01048
Keywords:
peptide formyl receptor 2 (ALX/FPR2) new ureidopropanamide agonist ALX/FPR2 resolution of inflammation depression
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_12: Prevention of human diseases
- NZ3_6: Cell neurobiology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: HARMONIA 9 - announced on 2017-06-14
Amount awarded: 1 238 986 PLN
Project start date (Y-m-d): 2018-05-24
Project end date (Y-m-d): 2023-05-23
Project duration:: 60 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.